Last reviewed · How we verify
NCT03992651: CTCO
Optical Transcutaneous Sensors of Capnia and Oxygenation
NA trial testing Measurements of capnia and tissue oxygenation by optical transcutaneous sensors in Blood Gas Monitoring, Transcutaneous in 20 participants. Completed in 11 October 2019.
13 June 2019
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 20 |
| Start date | 12 June 2019 |
| Primary completion | 13 June 2019 |
| Estimated completion | 11 October 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Measurements of capnia and tissue oxygenation by optical transcutaneous sensors
Conditions studied
- Blood Gas Monitoring, Transcutaneous — all drugs for Blood Gas Monitoring, Transcutaneous →
Sponsor
University Hospital, Grenoble
Who can join
Adults 18 to 50, any sex, with Blood Gas Monitoring, Transcutaneous. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims at validating new optical transcutaneous sensors to evaluate tissue capnia (CO2 partial pressure) and oxygenation (blood oxygen saturation) by comparing them to standard laboratory measurements (end tidal CO2 measurements and oxygen saturation by near-infrared spectroscopy).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Contact, high-resolution spatial diffuse reflectance imaging system for skin condition diagnosis: a first-in-human clinical trial.
Koenig A, Petitdidier N, Grateau H, Characoun S, et al · · 2021 · cited 2× · PMID 33515218 · DOI 10.1117/1.jbo.26.1.012706
Verify or expand the search:
- PubMed search for NCT03992651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03992651 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03992651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing